Q4 2023 Prothena Corporation PLC Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Prothena's Biosciences' fourth quarter and full-year 2023 financial results conference call. My name is Krista, and I will be your coordinator for today. (Operator Instructions) I would now like to turn the presentation over to Mark Johnson, Vice President of Investor Relations at Prothena. Please proceed.
Thank you, operator. Good afternoon, everyone, and welcome to today's call to review Prothena's business progress fourth quarter and full-year 2023 financial results and 2024 financial guidance. Please review the press release we issued earlier today, which is available on our website at prothena.com and is also attached to a Form 8-K filed today with the SEC. In addition, we are using supplemental slides which are available on our investor website's events and presentations section.
On today's call, Dr. Gene Kinney, our President and Chief Executive Officer will provide opening remarks including an overview of Prothena's corporate and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |